Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02928224 |
|---|---|
| Brief Title: | Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer (BEACON CRC) |
| First Submitted : | August 16, 2016 |
| First Submitted that Met QC Criteria : | October 6, 2016 |
| First Posted : | October 10, 2016 (Estimate) |
| Results First Submitted : | May 6, 2020 |
| Results First Submitted that Met QC Criteria : | June 19, 2020 |
| Results First Posted : | July 14, 2020 |
| Certification/Extension First Submitted : | December 19, 2019 |
| Certification/Extension First Submitted that Met QC Criteria : | December 19, 2019 |
| Certification/Extension First Posted : | December 20, 2019 |
| Last Update Submitted that Met QC Criteria : | December 1, 2023 |
| Last Update Posted : | December 21, 2023 |